Stone JM - Search Results

1

Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo.

Bressan RA, Erlandsson K, Stone JM, Mulligan RS, Krystal JH, Ell PJ, Pilowsky LS. Bressan RA, et al. Among authors: stone jm. Biol Psychiatry. 2005 Jul 1;58(1):41-6. doi: 10.1016/j.biopsych.2005.03.016. Biol Psychiatry. 2005. PMID: 15992521

2

Non-uniform blockade of intrastriatal D2/D3 receptors by risperidone and amisulpride.

Stone JM, Bressan RA, Erlandsson K, Ell PJ, Pilowsky LS. Stone JM, et al. Psychopharmacology (Berl). 2005 Aug;180(4):664-9. doi: 10.1007/s00213-005-2161-2. Epub 2005 Sep 14. Psychopharmacology (Berl). 2005. PMID: 15719226 Clinical Trial.

3

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.

Pilowsky LS, Bressan RA, Stone JM, Erlandsson K, Mulligan RS, Krystal JH, Ell PJ. Pilowsky LS, et al. Among authors: stone jm. Mol Psychiatry. 2006 Feb;11(2):118-9. doi: 10.1038/sj.mp.4001751. Mol Psychiatry. 2006. PMID: 16189506 Clinical Trial. No abstract available.

4

Antipsychotic drug action: targets for drug discovery with neurochemical imaging.

Stone JM, Pilowsky LS. Stone JM, et al. Expert Rev Neurother. 2006 Jan;6(1):57-64. doi: 10.1586/14737175.6.1.57. Expert Rev Neurother. 2006. PMID: 16466312 Review.

5

The contribution of brain imaging to understanding the mechanism of second generation antipsychotic drugs.

Pilowsky LS, Stone JM. Pilowsky LS, et al. Among authors: stone jm. Eur Psychiatry. 2006 Jul;21(5):347. doi: 10.1016/j.eurpsy.2006.01.008. Epub 2006 Mar 20. Eur Psychiatry. 2006. PMID: 16545545 No abstract available.

6

Ketamine displaces the novel NMDA receptor SPET probe [(123)I]CNS-1261 in humans in vivo.

Stone JM, Erlandsson K, Arstad E, Bressan RA, Squassante L, Teneggi V, Ell PJ, Pilowsky LS. Stone JM, et al. Nucl Med Biol. 2006 Feb;33(2):239-43. doi: 10.1016/j.nucmedbio.2005.12.001. Nucl Med Biol. 2006. PMID: 16546678 Clinical Trial.

7

[123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challenge.

Stone JM, Arstad E, Erlandsson K, Waterhouse RN, Ell PJ, Pilowsky LS. Stone JM, et al. Synapse. 2006 Aug;60(2):109-17. doi: 10.1002/syn.20281. Synapse. 2006. PMID: 16715498

8

Psychopathological consequences of ketamine.

Stone JM, Pilowsky LS. Stone JM, et al. Br J Psychiatry. 2006 Dec;189:565-6. doi: 10.1192/bjp.189.6.565b. Br J Psychiatry. 2006. PMID: 17139048 No abstract available.

9

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review.

Stone JM, Morrison PD, Pilowsky LS. Stone JM, et al. J Psychopharmacol. 2007 Jun;21(4):440-52. doi: 10.1177/0269881106073126. Epub 2007 Jan 26. J Psychopharmacol. 2007. PMID: 17259207 Review.

10

Novel targets for drugs in schizophrenia.

Stone JM, Pilowsky LS. Stone JM, et al. CNS Neurol Disord Drug Targets. 2007 Aug;6(4):265-72. doi: 10.2174/187152707781387323. CNS Neurol Disord Drug Targets. 2007. PMID: 17691983 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

233 results

Search Page

Filters